EGFR as a stable marker of prostate cancer dissemination to bones.

Paulina NastałySara StoupiecMarta PopędaJulia SmentochThorsten SchlommColm MorrisseyAnna Joanna ŻaczekBurkhard BeyerPierre TennstedtMarkus GraefenElke EltzePaolo MaiuriAxel SemjonowKlaus PantelBurkhard BrandtNatalia Bednarz-Knoll

Published in: British journal of cancer (2020)

EGFRover is a stable, EMT-independent marker of PCa disseminating to rigid organs, preferentially bones.

Keyphrases

prostate cancer
small cell lung cancer
radical prostatectomy
epithelial mesenchymal transition
epidermal growth factor receptor
tyrosine kinase